Staff and visitors to the Crick during the coronavirus outbreak Our priority is the safety of everyone at the Crick. We are closed to visitors, and staff are encouraged to work from home wherever possible.
Coronavirus (COVID-19) research Crick researchers are working at the forefront of the scientific response to answer some of the most urgent questions about the SARS-CoV-2 pathogen, from how we can improve testing, to why it’s deadly in some people but causes no symptoms in others.
Francis Crick Institute coronavirus (COVID-19) response The Francis Crick Institute is working at the forefront of the scientific response to coronavirus, volunteering expertise and facilities to help tackle the COVID-19 pandemic.
Search Results Fulltext search 183 Results Found Title to be confirmed Maria Manuel Dias da Mota | Instituto de Medicina Molecular João Lobo Antunes 21 September 2018 | 12:00 - 13:00 Breadcrumb Home What's on Title to be confirmed 'The pericentromere and chromosome segregation' Professor Adele Marston | Wellcome Trust Centre for Cell Biology, University of Edinburgh 21 September 2018 | 12:00 - 13:00 Breadcrumb Home What's on 'The pericentromere and c... Understanding and controlling protein: protein interactions in amyloid formation Sheena Radford | Astbury Professor of Biophysics | University of Leeds 26 September 2018 | 12:00 - 13:00 Breadcrumb Home What's on Understanding and control... Targeting iron dependent pathways for host-directed therapy of tuberculosis Alan Sher | NIH Distinguished Investigator, Deputy Chief | Laboratory of Parasitic Diseases | National Institute of Allergy and Infectious Diseases 2 October 2018 | 12:00 - 13:00 Breadcrumb Home What's on Targeting iron dependent ... Targeting MAP kinase signaling for the future therapy of RAS driven cancers Martin McMahon | Huntsman Cancer Institute & Dept. of Dermatology | University of Utah 4 October 2018 | 13:00 - 14:00 Breadcrumb Home What's on Targeting MAP kinase sign... NK cell differentiation in health and disease Yenan Bryceson | Group Leader | Department of Medicine | Karolinska Institutet 5 October 2018 | 12:00 - 13:00 Breadcrumb Home What's on NK cell differentiation i... Title to be confirmed Karl-Peter Hopfner | Structural Molecular Biology | Ludwig-Maximilians-Universität 12 October 2018 | 12:00 - 13:00 Breadcrumb Home What's on Title to be confirmed Innate lymphoid cells and the second brain Henrique Veiga-Fernandes | Principal Investigator | Champalimaud Center for the Unknown 12 October 2018 | 12:00 - 13:00 Breadcrumb Home What's on Innate lymphoid cells and... Title to be confirmed Paul Lehner | Professor | Cambridge Institute for Medical Research | University of Cambridge 19 October 2018 | 12:00 - 13:00 Breadcrumb Home What's on Title to be confirmed How the target affects DUBs in DNA repair Titia Sixma | Professor | The Netherlands Cancer Institute 28 November 2018 | 12:00 - 13:00 Breadcrumb Home What's on Titia Sixma Pagination First page First Previous page Previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next Last page Last
Title to be confirmed Maria Manuel Dias da Mota | Instituto de Medicina Molecular João Lobo Antunes 21 September 2018 | 12:00 - 13:00 Breadcrumb Home What's on Title to be confirmed
'The pericentromere and chromosome segregation' Professor Adele Marston | Wellcome Trust Centre for Cell Biology, University of Edinburgh 21 September 2018 | 12:00 - 13:00 Breadcrumb Home What's on 'The pericentromere and c...
Understanding and controlling protein: protein interactions in amyloid formation Sheena Radford | Astbury Professor of Biophysics | University of Leeds 26 September 2018 | 12:00 - 13:00 Breadcrumb Home What's on Understanding and control...
Targeting iron dependent pathways for host-directed therapy of tuberculosis Alan Sher | NIH Distinguished Investigator, Deputy Chief | Laboratory of Parasitic Diseases | National Institute of Allergy and Infectious Diseases 2 October 2018 | 12:00 - 13:00 Breadcrumb Home What's on Targeting iron dependent ...
Targeting MAP kinase signaling for the future therapy of RAS driven cancers Martin McMahon | Huntsman Cancer Institute & Dept. of Dermatology | University of Utah 4 October 2018 | 13:00 - 14:00 Breadcrumb Home What's on Targeting MAP kinase sign...
NK cell differentiation in health and disease Yenan Bryceson | Group Leader | Department of Medicine | Karolinska Institutet 5 October 2018 | 12:00 - 13:00 Breadcrumb Home What's on NK cell differentiation i...
Title to be confirmed Karl-Peter Hopfner | Structural Molecular Biology | Ludwig-Maximilians-Universität 12 October 2018 | 12:00 - 13:00 Breadcrumb Home What's on Title to be confirmed
Innate lymphoid cells and the second brain Henrique Veiga-Fernandes | Principal Investigator | Champalimaud Center for the Unknown 12 October 2018 | 12:00 - 13:00 Breadcrumb Home What's on Innate lymphoid cells and...
Title to be confirmed Paul Lehner | Professor | Cambridge Institute for Medical Research | University of Cambridge 19 October 2018 | 12:00 - 13:00 Breadcrumb Home What's on Title to be confirmed
How the target affects DUBs in DNA repair Titia Sixma | Professor | The Netherlands Cancer Institute 28 November 2018 | 12:00 - 13:00 Breadcrumb Home What's on Titia Sixma
